Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves First-in-Class Drug for Gastric Cancer
Zolbetuximab — now with the brand name Vyloy — is a monoclonal antibody to treat patients with advanced gastric and gastroesophageal cancers.
Novel Targeted Drug Approved for Stomach Cancers
The FDA approved zolbetuximab (Vyloy), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, in combination with chemotherapy for the first-line treatment of adults with advanced HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma,
FDA OKs Zolbetuximab for Gastric, Gastroesophageal Cancer
FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to identify claudin 18.2–positive tumors and thus patients who may be eligible to receive zolbetuximab.
FDA Approves VYLOYâ„¢ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
The FDA has approved zolbetuximab-clzb (VYLOY) as a first-line targeted therapy, in combination with chemotherapy, for the treatment of adults with advanced gastric and GEJ cancer.
FDA approves Astellas' gastric cancer therapy
The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's website showed on Friday.
Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy
After a prior rejection, Astellas can head into the weekend celebrating a class-first FDA approval for its new gastric cancer med Vyloy. | Astellas' Vyloy won an FDA approval to treat gastric or gastroesophageal junction adenocarcinoma patients whose tumors are CLDN18.
FDA approves Astellas’ Vyloy
The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, with fluoropyrimidine and platinum-containing chemotherapy, from Japanese drug major Astellas Pharma.
VYLOY: Astellas’ gastric cancer therapy approved in US
Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in combination with
Astellas Pharma's VYLOY Receives FDA Approval For Treatment Of Advanced Gastric And GEJ Cancer
Astellas Pharma Inc. (ALPMY, ALPMY) said that the U.S. Food and Drug Administration has approved VYLOY (zolbetuximab-clzb) in
Astellas Pharma's Cancer Drug Vyloy Gets FDA Approval
Astellas Pharma's drug Vyloy was approved for treatment of advanced gastric and gastroesophageal junction cancer by the Food and Drug Administration. The pharmaceutical company said Friday the FDA approved the drug for use in combination with fluoropyrimidine-and-platinum-containing chemotherapy.
6d
on MSN
Clinical trials confirm zolbetuximab's efficacy in gastric cancer
In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of ...
Knowridge
3d
Scientists find new treatment for gastric cancer
In Germany, around 17,000 people are diagnosed with gastric cancer every year, and it remains one of the deadliest cancers, ...
technologynetworks
23y
Drug Extends Survival in Gastric Cancer Clinical Trial
The results of these trials are very important for cancer research. They show that patients with advanced gastric cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Advance to World Series
Baldwin returns to 'SNL'
Reaches tentative union deal
Trump's Pennsylvania rally
Opens up on Russian camp
Ex-MN congressman dies
Challenges military listing
G7 ministers back Ukraine
Postpones US tour
Boat rider arrested in FL
Frozen waffles recalled
US deficit reaches $1.8T
Philip Zimbardo dies at 91
Probes near miss in Austin
New Mexico flash flooding
MS after game shooting
Rock & Roll HOF '24 class
CVS workers strike
Launches OneWeb mission
ISR strikes northern Gaza
Antitrust ruling delayed
NYC Halloween dog parade
Oakland fire burns homes
Bladder cancer drug pulled
Opioid suits settlement deal
Ferry dock collapses in GA
US probing documents leak
Orionids meteor shower
Urges support for Ukraine
Georgia beats Texas
Related topics
Vyloy
United States
Stomach cancer
Astellas Pharma
Feedback